John Ulrich, Meyer Christian, Rumpf Hans-Jürgen, Hapke Ulfert
Addiction Research Center, Institute of Epidemiology and Social Medicine, University of Greifswald, Walther-Rathenau-Str. 48, D-17487 Greifswald, Germany.
Drug Alcohol Depend. 2004 Dec 7;76(3):287-95. doi: 10.1016/j.drugalcdep.2004.06.004.
Evidence suggests that nicotine-dependent smokers are at increased risk for psychiatric comorbidity but general population data that included the number of nicotine dependence and withdrawal symptoms according to DSM-IV, the Fagerstrom Test for Nicotine Dependence (FTND), somatoform disorders and the number of psychiatric diagnoses are rare. The goal of the present study was to analyse relationships of smoking and nicotine dependence with psychiatric disease and whether psychiatric disease predicts the sustaining of smoking after three years.
Cohort study with a random adult population sample in a northern German region (N = 4075) including a baseline measurement of ever daily smokers aged 18-64 (n = 2458), a first follow-up of the current smokers at baseline (n = 1552) after 30 months and a second follow-up after 36 months. Measures included DSM-IV diagnoses by the Composite International Diagnostic Interview, FTND, smoking cessation by interview.
Current daily smokers showed higher odds of a substance use disorder other than nicotine dependence compared with never smokers (odds ratio, OR, 4.6; confidence interval, CI, 2.9-7.2), affective (OR 1.8; CI 1.4-2.5), anxiety (OR 1.6; CI 1.2-2.0) or somatoform disorder (OR 1.4; CI 1.0-1.8). DSM-IV nicotine dependence and the FTND were positively related with the number of psychiatric diagnoses. Psychiatric comorbidity did not predict the maintenance of smoking or quitting.
Findings of increased rates of mental disorders among smokers and nicotine-dependent smokers in the adult general population are supported by this study. The number of nicotine dependence and withdrawal symptoms are related to mental disorders. In addition, somatoform disorders show relationships with smoking similar to relationships with depressive or anxiety disorders. The intention to stop smoking should be proactively supported among these comorbid patients.
有证据表明,尼古丁依赖吸烟者患精神疾病合并症的风险增加,但包含根据《精神疾病诊断与统计手册》第四版(DSM-IV)确定的尼古丁依赖和戒断症状数量、尼古丁依赖程度弗吉斯特罗姆测试(FTND)、躯体形式障碍及精神疾病诊断数量的一般人群数据较为罕见。本研究的目的是分析吸烟及尼古丁依赖与精神疾病之间的关系,以及精神疾病是否能预测三年后吸烟行为的持续情况。
对德国北部地区的成年随机人群样本进行队列研究(N = 4075),包括对年龄在18 - 64岁的每日吸烟者(n = 2458)进行基线测量,对基线时的当前吸烟者(n = 1552)在30个月后进行首次随访,并在36个月后进行第二次随访。测量指标包括通过复合国际诊断访谈进行的DSM-IV诊断、FTND以及通过访谈确定的戒烟情况。
与从不吸烟者相比,当前每日吸烟者患除尼古丁依赖外的物质使用障碍的几率更高(优势比,OR,4.6;置信区间,CI,2.9 - 7.2),情感障碍(OR 1.8;CI 1.4 - 2.5)、焦虑障碍(OR 1.6;CI 1.2 - 2.0)或躯体形式障碍(OR 1.4;CI 1.0 - 1.8)。DSM-IV尼古丁依赖和FTND与精神疾病诊断数量呈正相关。精神疾病合并症并不能预测吸烟行为的维持或戒烟情况。
本研究支持了成年普通人群中吸烟者及尼古丁依赖吸烟者精神障碍患病率增加的研究结果。尼古丁依赖和戒断症状的数量与精神障碍有关。此外,躯体形式障碍与吸烟的关系类似于与抑郁或焦虑障碍的关系。对于这些合并症患者,应积极支持其戒烟意愿。